US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39052948.
- Also identified by DOI 10.1200/JCO.24.00100.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The FDA's directive to deal with delayed confirmatory trials: lessons from pralatrexate and belinostat for T-cell lymphoma.
Medical subject headings
- United States Food and Drug Administration
- Aminopterin
- Lymphoma, T-Cell
- Sulfonamides
- Hydroxamic Acids